End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.94 CNY | +2.94% | +4.52% | -8.10% |
Business Summary
Number of employees: 1,842
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Contrast Agent
82.7
%
| 1,753 | 82.2 % | 1,817 | 82.7 % | +3.64% |
Others
10.7
%
| 9 | 0.4 % | 236 | 10.7 % | +2,414.20% |
CDMO
4.4
%
| 52 | 2.4 % | 97 | 4.4 % | +87.54% |
Quinolone
2.1
%
| 54 | 2.5 % | 46 | 2.1 % | -14.32% |
Rental
0.0
%
| - | - | 1 | 0.0 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
60.6
%
| 1,176 | 62.9 % | 1,209 | 60.6 % | +2.85% |
Abroad
39.4
%
| 692 | 37.1 % | 787 | 39.4 % | +13.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Yi Shen
CEO | Chief Executive Officer | 44 | 09-08-31 |
Jun Feng Guo
DFI | Director of Finance/CFO | 39 | 22-12-25 |
Jian Hu
CHM | Chairman | 45 | 10-12-31 |
Jin Sheng Hu
BRD | Director/Board Member | 69 | 03-12-31 |
Chao Sun
SEC | Corporate Secretary | 37 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Fei Zhang
BRD | Director/Board Member | 45 | 23-05-08 |
Mei Ying Mao
BRD | Director/Board Member | 61 | 23-05-08 |
Jin Sheng Hu
BRD | Director/Board Member | 69 | 03-12-31 |
Jian Hu
CHM | Chairman | 45 | 10-12-31 |
Fang Wei Zhang
CHM | Chairman | 46 | 04-12-31 |
Ling Qiao Li
BRD | Director/Board Member | 45 | 20-04-26 |
Wei Yi Shen
CEO | Chief Executive Officer | 44 | 09-08-31 |
Gang Xu
BRD | Director/Board Member | - | 23-05-08 |
Xiao Ke Zhang
BRD | Director/Board Member | 46 | 23-05-08 |
Ji Ming Hu
BRD | Director/Board Member | 50 | 23-05-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 342,514,501 | 212,464,603 ( 62.03 %) | 0 | 62.03 % |
Company contact information
Zhejiang Starry Pharmaceutical Co., Ltd.
9 Fengxi West Road Modern Industrial Cluster Zone
317306, Taizhou
+
http://www.starrypharm.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.10% | 615M | |
+31.52% | 690B | |
+24.42% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.94% | 235B | |
+5.49% | 199B | |
-9.82% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 603520 Stock
- Company Zhejiang Starry Pharmaceutical Co.,Ltd.